Drug-Induced Liver Injury: Premarketing Clinical Evaluation
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 29, 2009
October 17, 2019
de53c59a-0e5e-4eeb-9106-8a5a0947edbc
Related Documents
Systemic Lupus Erythematosus --Developing Medical Products for Treatment
Guidance DocumentJune 22, 2010Center for Drug Evaluation and Research
Electronic Source Data in Clinical Investigations: Guidance for Industry
Guidance DocumentSeptember 18, 2013Center for Drug Evaluation and Research
Integrated Summaries of Effectiveness and Safety: Location Within the Common Technical Document
Guidance DocumentApril 21, 2009Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox